Literature DB >> 15757235

Ratings of early major depressive disorder symptom change during a brief psychiatric hospitalization.

Jeremy W Pettit1, Patricia M Averill, Adel A Wassef, Nelson P Gruber, Laurie Schneider.   

Abstract

Ratings of change in MDD severity during a brief psychiatric hospitalization were examined across informant sources to determine the extent of change from admission to discharge and if specific symptoms are especially likely to change. Study participants were 137 inpatients with a primary diagnosis of MDD. Symptom data were collected at admission and discharge from attending psychiatrists, nurses, and patients. Global ratings of MDD severity and specific MDD symptoms significantly decreased during the course of hospitalization. This effect held across informant sources. All symptoms were equally likely to change. Females were rated as more depressed at admission and discharge by psychiatrists, but no gender differences were seen in self-report or nurse ratings. Shorter length of stay and involuntary admission status were associated with greater reduction in MDD severity. The temporal course and magnitude of the symptom reduction may result in part from unique aspects of an inpatient setting or from an underreporting of symptoms. The association between a shorter length of stay and greater symptom reduction may reflect a distinction between treatment responders and nonresponders.

Entities:  

Mesh:

Year:  2005        PMID: 15757235     DOI: 10.1007/s11089-005-5579-x

Source DB:  PubMed          Journal:  Psychiatr Q        ISSN: 0033-2720


  21 in total

1.  Agreement between self- and clinician-rated suicidal symptoms in a clinical sample of young adults: explaining discrepancies.

Authors:  T E Joiner; M D Rudd; M H Rajab
Journal:  J Consult Clin Psychol       Date:  1999-04

Review 2.  Clinical significance of monitoring early symptom change to predict outcome.

Authors:  M H Trivedi; S M Baker
Journal:  J Clin Psychiatry       Date:  2001       Impact factor: 4.384

3.  Effects of reboxetine on Hamilton Depression Rating Scale factors from randomized, placebo-controlled trials in major depression.

Authors:  J M Ferguson; J Mendels; G E Schwart
Journal:  Int Clin Psychopharmacol       Date:  2002-03       Impact factor: 1.659

4.  A double-blind study of paroxetine, fluoxetine, and placebo in outpatients with major depression.

Authors:  M Fava; J D Amsterdam; J A Deltito; C Salzman; M Schwaller; D L Dunner
Journal:  Ann Clin Psychiatry       Date:  1998-12       Impact factor: 1.567

5.  Early predictors of two month response with mianserin and selective serotonin reuptake inhibitors and influence of definition of outcome on prediction.

Authors:  I Berlin; F Lavergne
Journal:  Eur Psychiatry       Date:  1998-05       Impact factor: 5.361

6.  Onset of improvement under fluoxetine and moclobemide.

Authors:  H Stassen; J Angst; A Delini-Stula
Journal:  Eur Psychiatry       Date:  1998-05       Impact factor: 5.361

7.  A regression analytical approach to estimate the onset of activity of antidepressants.

Authors:  H Müller; H J Möller
Journal:  Eur Psychiatry       Date:  1998-05       Impact factor: 5.361

8.  Decreasing length of stay: are there effects on outcomes of psychiatric hospitalization?

Authors:  P B Lieberman; S A Wiitala; B Elliott; S McCormick; S B Goyette
Journal:  Am J Psychiatry       Date:  1998-07       Impact factor: 18.112

9.  Agreement between patient self-report and clinician rating: concurrence between the BSI and the GAF among psychiatric inpatients.

Authors:  H L Piersma; J L Boes
Journal:  J Clin Psychol       Date:  1995-03

10.  12-month outcome of patients with major depression and comorbid psychiatric or medical illness (compound depression).

Authors:  G I Keitner; C E Ryan; I W Miller; R Kohn; N B Epstein
Journal:  Am J Psychiatry       Date:  1991-03       Impact factor: 18.112

View more
  5 in total

1.  Who receives antidepressants and what impact do they have? An acute-care study.

Authors:  Patricia M Averill; Adel A Wassef
Journal:  Psychiatr Q       Date:  2006

2.  Outcome and length of stay in psychiatric hospitalization, the experience of the University Clinic of Turin.

Authors:  Paola Rocca; C Mingrone; T Mongini; C Montemagni; L Pulvirenti; G Rocca; F Bogetto
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-07-08       Impact factor: 4.328

3.  Clinical outcome and length of stay in an Italian Psychiatric Emergency Service.

Authors:  T Frieri; C Montemagni; G Rocca; P Rocca; V Villari
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2012-10-30       Impact factor: 4.328

4.  Modeling trajectory of depressive symptoms among psychiatric inpatients: a latent growth curve approach.

Authors:  Joshua D Clapp; Anouk L Grubaugh; Jon G Allen; Jane Mahoney; John M Oldham; J Christopher Fowler; Tom Ellis; Jon D Elhai; B Christopher Frueh
Journal:  J Clin Psychiatry       Date:  2013-05       Impact factor: 4.384

5.  Hospital stay in patients admitted for acute bipolar manic episodes prescribed quetiapine immediate or extended release: a retrospective non-interventional cohort study (HOME).

Authors:  Oğuz Karamustafalıoğlu; Andreas Reif; Murad Atmaca; Domingo Gonzalez; Miriam Moreno-Manzanaro; Miguel Angel Gonzalez; Esteban Medina; Antonello Bellomo
Journal:  BMC Psychiatry       Date:  2014-08-31       Impact factor: 3.630

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.